Skip to main content
Home

Martha Gulati highlights 'exciting' progress in preventive cardiology

Video of Martha Gulati explaining preventive cardiology advanacements for obese patients. #AHA24 #AHA2024 #CVprev

Martha Gulati, MD, spoke to Cardiovascular Business at AHA Scientific Sessions 2024 about key developments in obesity treatment and CVD prevention.

  • Read more about Martha Gulati highlights 'exciting' progress in preventive cardiology

Medtronic using AI to identify more TAVR patients in need

artificial intelligence AI heart cardiology

Medtronic has launched new research into AI's potential to identify patients with severe aortic stenosis and other worrying symptoms. The company hopes to overcome longstanding health disparities and reach individuals who may otherwise go untreated.

  • Read more about Medtronic using AI to identify more TAVR patients in need

More than 1/3 of old strokes are incidentally detected on head CT

stroke

A new analysis in JACR estimates that spotting the signs of a previously undetected stroke could benefit up to 200,000 people in the United States every year.

  • Read more about More than 1/3 of old strokes are incidentally detected on head CT

Trump selects Emmy-winning TV personality Dr. Oz to head CMS

Dr. Mehmet Oz, MD - The Dr. Oz Show

Promotional photo from the Dr. Oz Show. 

President-elect Donald Trump announced the nomination of former "Dr. Oz Show" star Mehmet Oz just days after appointing Robert F. Kennedy Jr. as secretary of health. 

  • Read more about Trump selects Emmy-winning TV personality Dr. Oz to head CMS

FDA issues Class I recall of infusion pump batteries due to risk of burns

the words "FDA recall" on a board

Rechargeable batteries used on CADD-Solis Li-ion infusion systems may short out if damaged, possibly causing the case to melt. No injuries have been reported.

  • Read more about FDA issues Class I recall of infusion pump batteries due to risk of burns

Are providers too trusting of AI's advice?

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

“When we rely too much on whatever the computer tells us, that’s a problem."

  • Read more about Are providers too trusting of AI's advice?

Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment

Abbott FreeStyle Libre 3 CGM

FreeStyle Libre 3 image courtesy of of Abbott.

Abbott expects the new facility to produce more FreeStyle Libre 3 sensors than anywhere else in the world.

  • Read more about Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment

Pairing an alert system with CAD software halves time-to-treatment for pneumothorax

New data from the American Heart Association (AHA), published Jan. 25, 2023, in Circulation, suggests it resulted in a significant increase in the number of patients dying from cardiovascular disease (CVD) and a higher age-adjusted mortality rate. Oxygen Mask

By expediting communication between radiologists and referring providers when suspicious findings are identified, the system has great potential to improve clinical outcomes in real-world scenarios, authors of a new study in JACR suggest.

  • Read more about Pairing an alert system with CAD software halves time-to-treatment for pneumothorax

SAVR linked to higher 10-year survival rate than TAVR for low-risk patients

Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient

TAVR patients in this study were treated with early-generation devices that have since been updated, but researchers still believe their data are relevant to today's care teams.

  • Read more about SAVR linked to higher 10-year survival rate than TAVR for low-risk patients

Cardiologist examines the latest breakthroughs in coronary inflammation research

Deepak Bhatt, MD, MPH, MBA, director of the Mount Sinai Fuster Heart Hospital, explains the research and therapies in development to treat coronary inflammation. In 2023, the FDA cleared the use colchicine and since there has been an explosion of interest in this area. #TCT #TCT24 #TCT2024 #AHA24

Deepak Bhatt, MD, MPH, MBA, spoke to Cardiovascular Business about the growing importance of evaluating coronary inflammation in heart patients. There has been an explosion of interest in this area since the FDA's 2023 clearance of colchicine.

  • Read more about Cardiologist examines the latest breakthroughs in coronary inflammation research

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …441
    • Page 442
    • Page 443
    • Page 444
    • Current page 445
    • Page 446
    • Page 447
    • Page 448
    • Page 449 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme